| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 17, 2025 | Peterson Amy C. EVP Prod Dev Med Aff CMO | Sell | Exelixis, Inc. | EXEL | $45.47 | $3M | -13.52% |
| Mar 16, 2023 | Mar 20, 2023 | Peterson Amy C. EVP Chief Development Officer | Sell | Cytomx Therapeutics, Inc. | CTMX | $1.98 | $8,425 | -6.79% |
| Jul 20, 2022 | Jul 21, 2022 | Peterson Amy C. EVP Chief Development Officer | Sell | Cytomx Therapeutics, Inc. | CTMX | $1.42 | $10,612 | -10.64% |
| Dec 17, 2018 | Dec 19, 2018 | Peterson Amy C. CMO Immuno-oncology | Sell | Beigene, Ltd. | BGNE | $133.68 | $3M | -9.32% |
| Nov 08, 2018 | Nov 13, 2018 | Peterson Amy C. CMO Immuno-oncology | Sell | Beigene, Ltd. | BGNE | $120.2 | $5M | -17.05% |
| Aug 23, 2018 | Aug 24, 2018 | Peterson Amy C. CMO Immuno-oncology | Sell | Beigene, Ltd. | BGNE | $169.12 | $975,666 | -2.88% |
| Nov 13, 2017 | Nov 16, 2017 | Peterson Amy C. CMO Immuno-oncology | Sell | Beigene, Ltd. | BGNE | $82.96 | $298,747 | -1.58% |